Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,602 | 7,350 | 38,635 | 117,764 | 70,436 |
| Marketable Securities | N/A | N/A | 20,534 | N/A | N/A |
| Receivables | 2,336 | N/A | 11,043 | 3,313 | 1,706 |
| TOTAL | $88,234 | $7,548 | $73,424 | $127,625 | $75,721 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 16,992 | 19,122 | 22,046 |
| Other Non-Current Assets | 0 | 0 | 5,074 | 6,813 | 7,243 |
| TOTAL | $N/A | $N/A | $22,066 | $25,935 | $29,289 |
| Total Assets | $88,234 | $7,548 | $95,490 | $153,560 | $105,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,586 | 936 | 4,154 | 8,609 | 1,787 |
| Accrued Expenses | 5,474 | 1,424 | 10,746 | 16,836 | 7,731 |
| Other current liabilities | 1,978 | N/A | N/A | N/A | N/A |
| TOTAL | $12,038 | $2,360 | $36,583 | $50,561 | $22,145 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 20,824 | 25,116 | 12,627 |
| Other Non-Current Liabilities | 13,589 | 9,068 | 12,244 | 13,841 | 15,938 |
| TOTAL | $13,589 | $9,068 | $30,978 | $52,244 | $51,838 |
| Total Liabilities | $25,627 | $11,428 | $67,561 | $102,805 | $73,983 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,019 | 1,237 | 931 | 926 | 746 |
| Common Shares | 11 | N/A | 74 | 72 | 56 |
| Retained earnings | -93,735 | -76,301 | -290,421 | -257,144 | -211,406 |
| Other shareholders' equity | 3 | 70,603 | -254 | 829 | -295 |
| TOTAL | $62,607 | $-3,880 | $27,929 | $50,755 | $31,027 |
| Total Liabilities And Equity | $88,234 | $7,548 | $95,490 | $153,560 | $105,010 |